NuVasive is an innovations-based medical device company that focuses on the design, development and marketing of products for the surgical treatment of spine disorders. The company s goal is to provide safe and reproductable procedural solutions with platform technology for the treatment of lumbar and cervical degenerative conditions with maximum access with minimal disruption, continuous assessment of nerve safety, innovative implants for fusion and motion preservation solutions. Its proprietary maximum access surgery platform technology provides benefits to both surgeons and patients, including reduced surgery time, shorter hospital stays and faster recovery times. NuVasive maintains its headquarters and laboratory facilities in San Diego and a branch office in Munich, Germany. The company trades on NASDAQ under the symbol NUVA.
Partial Data by Infogroup (c) 2024. All rights reserved.